11.01.09
With a focus on eye health and joint health, Valensa International, Eustis, FL, has reached an agreement with Neptune Technologies & Bioressources Inc., Laval, Quebec, Canada, for an exclusive, worldwide license to incorporate and market Neptune Krill Oil (NKO) in condition-specific dietary supplement formulas. Valensa plans on using the unique functional properties of the highly bioavailable omega 3 phospholipids in NKO in conjunction with several of its proprietary ingredients such as Zanthin natural astaxanthin, extending its current platform of patented eye health formulations. Valensa has also developed and applied for IP protection for a new range of joint and eye health formulations featuring NKO and other ingredients. Valensa is in discussions with customers and plans to launch the new patent-pending eye and joint health formulations during the first quarter of 2010. The company is currently conducting clinical trials to demonstrate the effectiveness of these new formulations.